Gan & Lee Pharmaceutical: It has been confirmed that the company's subsidiary Ndogenikos in Russia is operating and producing normally jqknews

Post date April 7, 2022 — 19:53 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Gan & Lee Pharmaceutical (603087): 2021 Annual General Meeting of Shareholders CFi.CN

May 13, 2022 — 21:23

[China Securities Pre-market] The first-quarter net profit of "Chip One Brother" increased by more than 175%! Tenlian Board Xinhua Pharma Employee Stock Ownership Plan Clearance; Philips Plans to Transfer 10% of Entrepreneurship Huikang

May 13, 2022 — 09:48

Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval.

May 12, 2022 — 20:59

On the evening of May 12th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

May 12, 2022 — 19:50

Can insulin "price-for-volume" bring new revenue? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points.

May 1, 2022 — 00:19

The truth in the financial report: Can the "price-for-volume" of insulin in the pharmaceutical industry bring about new revenue growth? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points.

May 1, 2022 — 00:16

Can insulin "price-for-volume" bring new revenue? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points_Oriental Fortune Net

April 30, 2022 — 22:19

The truth in the financial report: Can the "price-for-volume" of insulin in the pharmaceutical industry bring about new revenue growth? Before the answer was revealed, Gan & Lee Pharmaceutical went overseas to find new profit growth points.

April 30, 2022 — 22:16

The truth in the financial report: Can the "price-for-volume" of insulin in the pharmaceutical industry bring about new revenue growth? Before the answer was announced, Gan & Lee Pharmaceutical went overseas to find new profit growth points

April 30, 2022 — 22:16

Home » News » Gan & Lee Pharmaceutical: It has been confirmed that the company's subsidiary Ndogenikos in Russia is operating and producing normally jqknews